324 related articles for article (PubMed ID: 11327761)
21. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
22. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
[TBL] [Abstract][Full Text] [Related]
23. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.
Osato M
Oncogene; 2004 May; 23(24):4284-96. PubMed ID: 15156185
[TBL] [Abstract][Full Text] [Related]
24. An enigmatic fourth runt domain gene in the fugu genome: ancestral gene loss versus accelerated evolution.
Glusman G; Kaur A; Hood L; Rowen L
BMC Evol Biol; 2004 Nov; 4():43. PubMed ID: 15527507
[TBL] [Abstract][Full Text] [Related]
25. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
[TBL] [Abstract][Full Text] [Related]
26. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
27. Energetic contribution of residues in the Runx1 Runt domain to DNA binding.
Li Z; Yan J; Matheny CJ; Corpora T; Bravo J; Warren AJ; Bushweller JH; Speck NA
J Biol Chem; 2003 Aug; 278(35):33088-96. PubMed ID: 12807882
[TBL] [Abstract][Full Text] [Related]
28. Solution properties of the free and DNA-bound Runt domain of AML1.
Wolf-Watz M; Xie XQ; Holm M; Grundström T; Härd T
Eur J Biochem; 1999 Apr; 261(1):251-60. PubMed ID: 10103057
[TBL] [Abstract][Full Text] [Related]
29. The dimerization domain of HNF-1alpha: structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus.
Narayana N; Hua Q; Weiss MA
J Mol Biol; 2001 Jul; 310(3):635-58. PubMed ID: 11439029
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
[TBL] [Abstract][Full Text] [Related]
31. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development.
Fujita Y; Nishimura M; Taniwaki M; Abe T; Okuda T
Biochem Biophys Res Commun; 2001 Mar; 281(5):1248-55. PubMed ID: 11243869
[TBL] [Abstract][Full Text] [Related]
32. DNA-binding by Ig-fold proteins.
Rudolph MJ; Gergen JP
Nat Struct Biol; 2001 May; 8(5):384-6. PubMed ID: 11323707
[No Abstract] [Full Text] [Related]
33. Identification of the region of mi transcription factor which is responsible for the synergy with PEBP2/CBF.
Morii E; Ogihara H; Kanno T; Kim DK; Nomura S; Ito Y; Kitamura Y
Biochem Biophys Res Commun; 1999 Jul; 261(1):53-7. PubMed ID: 10405322
[TBL] [Abstract][Full Text] [Related]
34. Identification of amino acid residues of transcription factor AP-2 involved in DNA binding.
García MA; Campillos M; Ogueta S; Valdivieso F; Vázquez J
J Mol Biol; 2000 Aug; 301(4):807-16. PubMed ID: 10966787
[TBL] [Abstract][Full Text] [Related]
35. The runt protein and its companion PEBP2: a close link between this transcription factor and AML.
Ito Y
Leukemia; 1997 Apr; 11 Suppl 3():279-80. PubMed ID: 9209364
[No Abstract] [Full Text] [Related]
36. The bZIP region of the plant transcription factor opaque-2 forms stable homodimers in solution and retains its helical structure upon subunit dissociation.
Moreau VH; da Silva AC; Siloto RM; Valente AP; Leite A; Almeida FC
Biochemistry; 2004 Apr; 43(16):4862-8. PubMed ID: 15096055
[TBL] [Abstract][Full Text] [Related]
37. Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31.
Namba K; Abe M; Saito S; Satake M; Ohmoto T; Watanabe T; Sato Y
Oncogene; 2000 Jan; 19(1):106-14. PubMed ID: 10644985
[TBL] [Abstract][Full Text] [Related]
38. The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.
Han MS; Kim HJ; Wee HJ; Lim KE; Park NR; Bae SC; van Wijnen AJ; Stein JL; Lian JB; Stein GS; Choi JY
J Cell Biochem; 2010 May; 110(1):97-103. PubMed ID: 20225274
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia.
Otto F; Kanegane H; Mundlos S
Hum Mutat; 2002 Mar; 19(3):209-16. PubMed ID: 11857736
[TBL] [Abstract][Full Text] [Related]
40. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
